Enclara Pharmacia | May 15, 2018

Enclara Pharmacia Inks Five-Year Contract Extension with VITAS Healthcare


Continues Highest Service Levels for Patient Medication Management

PHILADELPHIA / MIAMI – May 15, 2018 – Enclara Pharmacia (Enclara), the market leader in comprehensive pharmacy benefits management (PBM) services to the hospice community, announces a five-year contract extension to provide comprehensive patient medication management services to VITAS Healthcare, the nation’s leading provider of end-of-life care. This contract extension reaffirms a mutual commitment to innovation and a shared focus on prioritizing the medication management needs of VITAS patients

Nick Westfall, CEO, VITAS, says, “This partnership extension underscores our confidence in Enclara’s exemplary customer service and support capabilities. Their market-leading programmatic innovation helps forward our business and assists us in tackling market challenges.”

Reiterating the value of this partnership and the importance of VITAS in the Enclara customer portfolio, Andy Horowitz, CEO of Enclara, says, “We are extremely gratified to extend our relationship with VITAS. As respected innovators and leaders in the hospice and palliative community, VITAS has driven us to improve our level of collaboration in developing clinical and technological solutions. Improving the patient experience and care quality, while improving organizational efficiency, is a unifying mission between Enclara and VITAS.”

He points to their shared history of dedication to clinical quality and enhancing the client experience, noting, “These are woven into every aspect of our day-to-day working relationship, and meaningful interactions with Vitas executives John Paglino and Dan Quinn, clinical team leaders who have championed industry advances and protocols in patient care.  The next five years will provide an opportunity for both organizations to keep innovating together to further enhance patient-centric care at the end-of-life.”

Horowitz emphasizes the significance of Enclara’s robust clinical support and technology solutions, adding, “We are committed to providing the hospice community the best patient management experience through unmatched medication access, clinical excellence, and innovative technology solutions that increase staff efficiencies, while effectively addressing the cost of care.”

About Enclara Pharmacia
Enclara Pharmacia is a national full-service PBM and mail order supplier of medications and clinical services developed specifically for the hospice and palliative care industry. Enclara services over 500 customers and 90,000 patients nationally, helping to reduce pharmacy costs through a clinically driven model that enables home delivery of pharmaceuticals, as well as access to a network of over 65,000 retail pharmacies, including our own automated fulfillment pharmacies, and institutional pharmacies. For more information, visit www.enclarapharmacia.com.